• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

通过被动免疫预防HIV感染的前景。

Prospects for passive immunity to prevent HIV infection.

作者信息

Morris Lynn, Mkhize Nonhlanhla N

机构信息

National Institute for Communicable Diseases of the National Health Laboratory Service and the University of the Witwatersrand, Johannesburg, South Africa.

Center for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.

出版信息

PLoS Med. 2017 Nov 14;14(11):e1002436. doi: 10.1371/journal.pmed.1002436. eCollection 2017 Nov.

DOI:10.1371/journal.pmed.1002436
PMID:29136030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5685477/
Abstract

In a Perspective, Lynn Morris and Nonhlanhla Mkhize discuss the prospects for broadly neutralizing antibodies to be used in preventing HIV infection.

摘要

在一篇《观点》文章中，林恩·莫里斯和诺赫兰赫拉·姆基泽探讨了广泛中和抗体用于预防HIV感染的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3aa/5685477/c9b971d89108/pmed.1002436.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3aa/5685477/c9b971d89108/pmed.1002436.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3aa/5685477/c9b971d89108/pmed.1002436.g001.jpg

相似文献

1
Prospects for passive immunity to prevent HIV infection.通过被动免疫预防HIV感染的前景。
PLoS Med. 2017 Nov 14;14(11):e1002436. doi: 10.1371/journal.pmed.1002436. eCollection 2017 Nov.
2
Insights from HIV-1 vaccine and passive immunization efficacy trials.从 HIV-1 疫苗和被动免疫效力试验中获得的见解。
Trends Mol Med. 2024 Oct;30(10):908-912. doi: 10.1016/j.molmed.2024.05.017. Epub 2024 Jun 18.
3
In vivo protection by broadly neutralizing HIV antibodies.HIV 广谱中和抗体的体内保护作用。
Trends Microbiol. 2014 Oct;22(10):550-1. doi: 10.1016/j.tim.2014.08.006. Epub 2014 Aug 26.
4
Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.影响Fc介导的体外和体内效应功能效力的定性和定量变量：使用非中和抗体进行被动免疫的考量
Curr HIV Res. 2013 Jul;11(5):354-64. doi: 10.2174/1570162x113116660060.
5
Broadly neutralizing antibodies against HIV-1: templates for a vaccine.广谱中和抗体抗 HIV-1：疫苗的模板。
Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004.
6
Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIV.被动免疫中来自自身的竞争模型，应用于 HIV 的广谱中和抗体。
Vaccine. 2012 Jan 11;30(3):607-13. doi: 10.1016/j.vaccine.2011.11.048. Epub 2011 Nov 23.
7
Progress in HIV vaccine development.HIV疫苗研发进展。
Hum Vaccin Immunother. 2017 May 4;13(5):1018-1030. doi: 10.1080/21645515.2016.1276138. Epub 2017 Mar 10.
8
Neutralizing antibodies take a swipe at HIV in vivo.中和抗体在体内对艾滋病毒发起攻击。
Nat Med. 2005 Jun;11(6):593-4. doi: 10.1038/nm0605-593.
9
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.靶向V3环C末端区域的母体结合性和中和性IgG反应可预测围产期HIV-1传播风险降低。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02422-16. Print 2017 May 1.
10
Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.简短通讯：探索抗体作为预防早期黏膜HIV-1感染的预防/治疗策略的潜力。
AIDS Res Hum Retroviruses. 2015 Nov;31(11):1187-91. doi: 10.1089/AID.2015.0041. Epub 2015 Sep 10.

引用本文的文献

1
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.人类免疫缺陷病毒1型疫苗研究的进展与挑战：全面综述
Vaccines (Basel). 2025 Jan 31;13(2):148. doi: 10.3390/vaccines13020148.
2
Unveiling the role of adhesin proteins in controlling infections: a systematic review.揭示黏附素蛋白在控制感染中的作用：一项系统综述。
Infect Immun. 2025 Feb 18;93(2):e0034824. doi: 10.1128/iai.00348-24. Epub 2025 Jan 8.
3
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy.mRNA 抗体药物介导的被动免疫治疗的机制及研究进展。

本文引用的文献

1
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.对未感染HIV的成年人多次静脉注射或皮下注射抗HIV单克隆抗体VRC01的安全性、药代动力学和免疫活性：1期随机试验结果
PLoS Med. 2017 Nov 14;14(11):e1002435. doi: 10.1371/journal.pmed.1002435. eCollection 2017 Nov.
2
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.三特异性广泛中和HIV抗体在猕猴中介导对猿猴免疫缺陷病毒的有效保护。
Science. 2017 Oct 6;358(6359):85-90. doi: 10.1126/science.aan8630. Epub 2017 Sep 20.
3
J Transl Med. 2023 Oct 4;21(1):693. doi: 10.1186/s12967-023-04553-1.
4
HIV-1 transmission: modelling and direct visualization in the third dimension.HIV-1 传播：三维建模和直接可视化。
Microscopy (Oxf). 2023 Jun 8;72(3):164-177. doi: 10.1093/jmicro/dfad014.
5
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot.从超分子水凝胶库中皮下递送针对 SARS-CoV-2 的抗体。
Biomater Sci. 2023 Mar 14;11(6):2065-2079. doi: 10.1039/d2bm00819j.
6
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis.抗体介导的效应功能对 HIV 预防和治疗的贡献以及通过载体免疫预防广泛中和抗体传递的进展。
Front Immunol. 2021 Sep 15;12:734304. doi: 10.3389/fimmu.2021.734304. eCollection 2021.
7
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.利用广谱中和抗体作为人类免疫缺陷病毒的预防和治疗应用。
Front Immunol. 2021 Jul 20;12:697683. doi: 10.3389/fimmu.2021.697683. eCollection 2021.
8
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.以HIV为对照描绘的新型冠状病毒2：相似伪装下的相反病毒策略
Microorganisms. 2021 Jun 27;9(7):1389. doi: 10.3390/microorganisms9071389.
9
Super LeArner Prediction of NAb Panels (SLAPNAP): a containerized tool for predicting combination monoclonal broadly neutralizing antibody sensitivity.Super LeArner 预测 NAb 面板 (SLAPNAP)：一种用于预测组合单克隆广泛中和抗体敏感性的集装箱工具。
Bioinformatics. 2021 Nov 18;37(22):4187-4192. doi: 10.1093/bioinformatics/btab398.
10
Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.潜伏储库中预先存在的耐药性可能会影响慢性 HIV-1 感染期间的 VRC01 治疗效果。
PLoS Comput Biol. 2020 Nov 30;16(11):e1008434. doi: 10.1371/journal.pcbi.1008434. eCollection 2020 Nov.
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.
广谱中和抗体针对 HIV-1 包膜 V2 顶点赋予对 clade C SHIV 挑战的保护。
Sci Transl Med. 2017 Sep 6;9(406). doi: 10.1126/scitranslmed.aal1321.
4
Preventing acquisition of HIV is the only path to an AIDS-free generation.预防感染艾滋病毒是实现无艾滋病一代的唯一途径。
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3798-3800. doi: 10.1073/pnas.1703236114. Epub 2017 Mar 30.
5
Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.以腺相关病毒载体进行抗体基因转移作为预防艾滋病病毒的一种方法。
Immunol Rev. 2017 Jan;275(1):324-333. doi: 10.1111/imr.12478.
6
Use of broadly neutralizing antibodies for HIV-1 prevention.使用广泛中和抗体预防HIV-1感染。
Immunol Rev. 2017 Jan;275(1):296-312. doi: 10.1111/imr.12511.
7
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.HIV抗体VRC01对治疗中断后病毒反弹的影响。
N Engl J Med. 2016 Nov 24;375(21):2037-2050. doi: 10.1056/NEJMoa1608243. Epub 2016 Nov 9.
8
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.鉴定一种对HIV具有近泛中和广度的CD4结合位点抗体。
Immunity. 2016 Nov 15;45(5):1108-1121. doi: 10.1016/j.immuni.2016.10.027.
9
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.具有卓越HIV-1中和活性的工程化双特异性抗体。
Cell. 2016 Jun 16;165(7):1621-1631. doi: 10.1016/j.cell.2016.05.024.
10
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.具有增强广度和效力的双特异性抗HIV-1抗体。
Cell. 2016 Jun 16;165(7):1609-1620. doi: 10.1016/j.cell.2016.04.050.